◆
Directly stimulates dermal papilla cells, the cellular control center of hair growth.
FREE SHIPPING ON ORDERS OVER $100
Dose ranges reflect commonly studied amounts in published research models. This is not medical advice. For research use only. Not for human consumption.
Protocol Comparison
Hair Growth · Skin · Regeneration
Research dose range
Standard research range
0.5 - 1 mg
Most referenced range in AHK-Cu hair follicle density and VEGF pathway research.
Research focus
Follicle activation
Observed window
8-12 weeks
Administration
Daily
Primary pathway
VEGF / Dermal papilla cells
AHK-Cu shown in 2007 Seoul National University study to stimulate human hair follicle elongation in vitro.
PROTOCOL BENEFITS
◆
Directly stimulates dermal papilla cells, the cellular control center of hair growth.
◆
Promotes angiogenesis in the scalp, nourishing follicles and extending the growth phase.
◆
Human tissue research shows dual benefit for hair density and skin collagen.
SCIENCE
AHK-Cu is a next-generation copper peptide, a close analog of GHK-Cu optimized for hair follicle biology.
It works by activating VEGF and supporting fibroblast proliferation, building the cellular infrastructure healthy hair growth depends on.
WHAT TO EXPECT
An initial shedding phase may occur in weeks 1-3. Density and thickness improvements are typically observed at 8-12 weeks.
PROTOCOL NOTE
Available in 50mg. For research use only. Full usage documentation included with every order.
RELATED PRODUCTS